SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-026945
Filing Date
2021-11-02
Accepted
2021-11-02 14:00:44
Documents
13
Period of Report
2021-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43398
2 ex99-1.htm EX-99.1 13499
  Complete submission text file 0001493152-21-026945.txt   229477

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE musclepharmcom-20211028.xsd EX-101.SCH 3063
4 XBRL LABEL FILE musclepharmcom-20211028_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE musclepharmcom-20211028_pre.xml EX-101.PRE 22374
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3316
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53166 | Film No.: 211370333
SIC: 2834 Pharmaceutical Preparations